Wolff Wiese Magana’s Olema Pharmaceuticals OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.51K Hold
600
﹤0.01% 554
2026
Q1
$8.95K Hold
600
﹤0.01% 486
2025
Q4
$15K Hold
600
0.01% 358
2025
Q3
$5.87K Hold
600
﹤0.01% 562
2025
Q2
$2.56K Hold
600
﹤0.01% 682
2025
Q1
$2.26K Hold
600
﹤0.01% 714
2024
Q4
$3.5K Hold
600
﹤0.01% 619
2024
Q3
$7.16K Hold
600
﹤0.01% 507
2024
Q2
$6.49K Hold
600
0.01% 384
2024
Q1
$6.79K Buy
+600
New +$7.74K 0.01% 348

Other funds holding OLMA

Wolff Wiese Magana's OLMA Position: Q2 2026 in Review

Wolff Wiese Magana held its Olema Pharmaceuticals (OLMA) position steady in Q2 2026 at 600 shares worth $7.51K. The position accounts for ﹤0.01% of the portfolio, ranked #554.

Wolff Wiese Magana first reported a position in OLMA in Q1 2024 and has held it in 10 quarters since. The position peaked at $15K in Q4 2025. 10 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Wolff Wiese Magana held 600 shares of Olema Pharmaceuticals worth $7.51K as of Q2 2026.
  • Wolff Wiese Magana left its Olema Pharmaceuticals share count unchanged in Q2 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Wolff Wiese Magana's portfolio in Q2 2026, its #554 holding.
  • Wolff Wiese Magana first reported a position in Olema Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • Wolff Wiese Magana's Olema Pharmaceuticals position peaked at $15K in Q4 2025.
  • 10 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.